Liquid chromatography/tandem mass spectrometry detection of covalent binding of acetaminophen to human serum albumin

Drug Metabolism and Disposition

Volumn 35, Issue 8, 2007, Pages 1408-1417

  Damsten, Micaela C ^a   Commandeur, Jan N M ^a   Fidder, Alex ^b   Hulst, Albert G ^b   Touw, Daan ^c   Noort, Daan ^b   Vermeulen, Nico P E ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b TNO   (Netherlands)

^c Apotheek Haagse Ziekenhuizen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; PARACETAMOL; SERUM ALBUMIN;

ARTICLE; BIOLOGICAL MONITORING; COVALENT BOND; DRUG PROTEIN BINDING; HUMAN; LIQUID CHROMATOGRAPHY; MICROSOME; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ACETAMINOPHEN; ACETYLCYSTEINE; ANIMALS; BENZOQUINONES; CHROMATOGRAPHY, LIQUID; CYSTEINE; HUMANS; IMINES; MICROSOMES, LIVER; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; OLIGOPEPTIDES; PROTEIN BINDING; RATS; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN; TANDEM MASS SPECTROMETRY;

EID: 34547141383     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.014233     Document Type: Article

References (40)

1. Axworthy DB, Hoffmann KJ, Streeter AJ, Calleman CJ, Pascoe GA, and Baillie TA (1988) Covalent binding of acetaminophen to mouse hemoglobin. Identification of major and minor adducts formed in vivo and implications for the nature of the arylating metabolites. Chem Biol Interact 68:99-116.
2. Bartolone JB, Birge RB, Sparks K, Cohen SD, and Khairallah EA (1988) Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins. Biochem Pharmacol 37:4763-4774.
3. Bessems JG, Te Koppele JM, Van Dijk PA, Van Stee LL, Commandeur JN, and Vermeulen NP (1996) Rat liver microsomal cytochrome P450-dependent oxidation of 3,5-disubstituted analogues of paracetamol. Xenobiotica 26:647-666.
4. Bessems JG and Vermeulen NP (2001) Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol 31:55-138.
5. Caldwell GW and Yan Z (2006) Screening for reactive intermediates and toxicity assessment in drug discovery. Curr Opin Drug Discov Devel 9:47-60.
6. Chen W, Shockcor JP, Tonge R, Hunter A, Gartner C, and Nelson SD (1999) Protein and nonprotein cysteinyl thiol modification by N-acetyl-p-benzoquinone imine via a novel ipso adduct. Biochemistry 38:8159-8166.
7. Commandeur JN, Stijntjes GJ, and Vermeulen NP (1995) Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. Pharmacol Rev 47:271-330.
8. Eaton P (2006) Protein thiol oxidation in health and disease: techniques for measuring disulfides and related modifications in complex protein mixtures. Free Radic Biol Med 40:1889-1899.
9. Evans DC, Watt AP, Nicoll-Griffith DA, and Baillie TA (2004) Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem Res Toxicol 17:3-16.
10. Gibson JD, Pumford NR, Samokyszyn VM, and Hinson JA (1996) Mechanism of acetaminophen-induced hepatotoxicity: covalent binding versus oxidative stress. Chem Res Toxicol 9:580-585.
11. Harada D, Naito S, and Otagiri M (2002) Kinetic analysis of covalent binding between N-acetyl-L-cysteine and albumin through the formation of mixed disulfides in human and rat serum in vitro. Pharmacol Res 19:1648-1654.
12. Hoffmann KJ, Streeter AJ, Axworthy DB, and Baillie TA (1985) Structural characterization of the major covalent adduct formed in vitro between acetaminophen and bovine serum albumin. Chem Biol Interact 53:155-172.
13. James LP, Alonso EM, Hynan LS, Hinson JA, Davern TJ, Lee WM, and Squires RH (2006) Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause. Pediatrics 118:676-681.
14. James LP, Farrar HC, Sullivan JE, Givens TG, Kearns GL, Wasserman GS, Walson PD, Hinson JA, and Pumford NR (2001) Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses. J Clin Pharmacol 41:846-851.
15. James LP, Mayeux PR, and Hinson JA (2003) Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 31:1499-1506.
16. Matthews AM, Roberts DW, Hinson JA, and Pumford NR (1996) Acetaminophen-induced hepatotoxicity. Analysis of total covalent binding vs. specific binding to cysteine. Drug Metab Dispos 24:1192-1196.
17. Muldrew KL, James LP, Coop L, McCullough SS, Hendrickson HP, Hinson JA, and Mayeux PR (2002) Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metab Dispos 30:446-451.
18. Noort D, Fidder A, Hulst AG, Woolfitt AR, Ash D, and Barr JR (2004) Retrospective detection of exposure to sulfur mustard: improvements on an assay for liquid chromatography-tandem mass spectrometry analysis of albumin-sulfur mustard adducts. J Anal Toxicol 28:333-338.
19. Noort D, Hulst AG, de Jong LP, and Benschop HP (1999) Alkylation of human serum albumin by sulfur mustard in vitro and in vivo: mass spectrometric analysis of a cysteine adduct as a sensitive biomarker of exposure. Chem Res Toxicol 12:715-721.
20. Noort D, Hulst AG, and Jansen R (2002) Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin. Arch Toxicol 76:83-88.
21. Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W, et al. (2000) Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 32:56-67.
22. Omland O, Sherson D, Hansen AM, Sigsgaard T, Autrup H, and Overgaard E (1994) Exposure of iron foundry workers to polycyclic aromatic hydrocarbons: benzo(a)pyrene-albumin adducts and 1-hydroxypyrene as biomarkers for exposure. Occup Environ Med 51:513-518.
23. Park BK, Kitteringham NR, Powell H, and Pirmohamed M (2000) Advances in molecular toxicology - towards understanding idiosyncratic drug toxicity. Toxicology 153:39-60.
24. Park K, Williams DP, Naisbitt DJ, Kitteringham NR, and Pirmohamed M (2005) Investigation of toxic metabolites during drug development. Toxicol Appl Pharmacol 207:425-434.
25. Pumford NR, Halmes NC, Martin BM, Cook RJ, Wagner C, and Hinson JA (1997) Covalent binding of acetaminophen to N-10-formyltetrahydrofolate dehydrogenase in mice. J Pharmacol Exp Ther 280:501-505.
26. Qiu Y, Benet LZ, and Burlingame AL (1998) Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. J Biol Chem 273:17940-17953.
27. Rappaport SM, Waidyanatha S, Yeowell-O'Connell K, Rothman N, Smith MT, Zhang L, Qu Q, Shore R, Li G, and Yin S (2005) Protein adducts as biomarkers of human benzene metabolism. Chem Biol Interact 153-154:103-109.
28. Roberts DW, Pumford NR, Potter DW, Benson RW, and Hinson JA (1987) A sensitive immunochemical assay for acetaminophen-protein adducts. J Pharmacol Exp Ther 241:527-533.
29. Rooseboom M, Commandeur JN, Floor GC, Rettie AE, and Vermeulen NP (2001) Selenoxidation by flavin-containing monooxygenases as a novel pathway for beta-elimination of selenocysteine Se-conjugates. Chem Res Toxicol 14:127-134.
30. Sherson D, Sabro P, Sigsgaard T, Johansen F, and Autrup H (1990) Biological monitoring of foundry workers exposed to polycyclic aromatic hydrocarbons. Br J Ind Med 47:448-453.
31. Smith DA and Schmid EF (2006) Drug withdrawals and the lessons within. Curr Opin Drug Discov Devel 9:38-46.
32. Tornqvist M, Fred C, Haglund J, Helleberg H, Paulsson B, and Rydberg P (2002) Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications. J Chromatogr B Analyt Technol Biomed Life Sci 778:279-308.
33. Uetrecht JP (1999) New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system. Chem Res Toxicol 12:387-395.
34. van Welie RT, van Dijck RG, Vermeulen NP, and van Sittert NJ (1992) Mercapturic acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals. Crit Rev Toxicol 22:271-306.
35. Wild CP, Jiang YZ, Sabbioni G, Chapot B, and Montesano R (1990) Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. Cancer Res 50:245-251.
36. Williams DP, Kitteringham NR, Naisbitt DJ, Pirmohamed M, Smith DA, and Park BK (2002) Are chemically reactive metabolites responsible for adverse reactions to drugs? Curr Drug Metab 3:351-366.
37. Yang XX, Hu ZP, Chan SY, and Zhou SF (2006) Monitoring drug-protein interaction. Clin Chim Acta 365:9-29.
38. Zhou L, McKenzie BA, Eccleston ED Jr, Srivastava SP, Chen N, Erickson RR, and Holtzman JL (1996) The covalent binding of [14C]acetaminophen to mouse hepatic microsomal proteins: the specific binding to calreticulin and the two forms of the thiol:protein disulfide oxidoreductases. Chem Res Toxicol 9:1176-1182.
39. Zhou S (2003) Separation and detection methods for covalent drug-protein adducts. J Chromatogr B Analyt Technol Biomed Life Sci 797:63-90.
40. Zhou S, Chan E, Duan W, Huang M, and Chen YZ (2005) Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug Metab Rev 37:41-213.